Can You Advertise GLP-1 Weight-Loss Drugs Like Ozempic on Google Ads?
No, not by name without certification. Google restricts prescription drug ads, including GLP-1 drugs like Ozempic, unless advertisers get an exception.

No — not by name, and not without clearing Google's exception process first. Google Ads restricts the promotion of services related to the online prescribing, dispensing, and sale of prescription drugs, a category that covers GLP-1 weight-loss drugs like Ozempic, Wegovy, and Mounjaro. Advertisers who want to use these drug names in ad text, landing pages, or keywords must contact Google directly to request an exception.
The Policy Covers the Service, Not Just the Drug Name
Google's restriction is built around businesses that prescribe, dispense, or sell prescription drugs online — the policy language names online pharmacies and telemedicine providers specifically as businesses subject to it. A telehealth company offering GLP-1 prescriptions through an online consultation falls squarely into this category, which is why GLP-1 advertisers tend to need pharmaceutical-specific review, not just a standard healthcare-ads check.
Certification Is the Route In, Not a Loophole
Trade guidance for 2026 describes GLP-1s and other prescription weight-loss drugs as requiring separate pharmaceutical certification from Google, plus formal authorization tied to the advertiser's healthcare organization, before drug names can appear in campaigns. That's consistent with Google's own exception-request language — certification doesn't bypass the restriction, it's the documented process for getting a specific, limited permission to use the otherwise-restricted terms.
Misleading Claims Are a Separate, Common Disapproval Trigger
Even certified advertisers aren't clear of risk once drug names are approved. Industry reporting points to a rise in "Misleading Representation" disapprovals for telehealth ads that fail to disclose when they're promoting a compounded version of a drug rather than the branded product — compounded semaglutide marketed without that distinction against branded Ozempic or Wegovy is a specific, recurring disapproval pattern, separate from the certification requirement itself.
Merchant Center Loosened One Specific Adjacent Rule in 2026
As of a March 2026 update, Google began allowing certified merchants to promote prescription drugs with recurring billing and bundled services in Shopping — for example, a GLP-1 prescription bundled with weight-loss coaching — as long as the prescription drug remains the primary product in the bundle. This is a narrow change to a specific merchant-program rule, not a general relaxation of the underlying prescription-drug restriction on Search or Display.
Shopping Ads Run Under a Stricter, Separate Layer
Standard Search and Display policy isn't the only layer that applies to GLP-1 advertisers running Shopping campaigns. Google Merchant Center's healthcare and medicines policy can block promotion of any drug that's been the subject of a government or regulatory action or warning, which is a broader and more dynamic restriction than the fixed certification process that applies to standard text ads.
Bottom Line
If you're advertising a GLP-1 program, don't name the drug anywhere in your campaign until you've gone through Google's pharmaceutical certification and exception-request process — and once certified, keep compounded-versus-branded disclosures explicit in your copy, since that's an active disapproval trigger independent of the certification itself.
Sources: Google Ads Policy Help, "Healthcare and medicines" (support.google.com/adspolicy/answer/176031); Google Merchant Center Policy, "Healthcare and medicines" (support.google.com/merchants/answer/6150151); trade reporting on 2026 Google Ads health-advertiser certification requirements.
Pro Tip
Always test your campaigns with small budgets first. Scale up only after you've proven profitability and optimized your conversion funnel.
Tags
Ready to Implement These Strategies?
Get personalized guidance on implementing these tactics for your specific business goals.
Related Articles
The Complete Guide to Google Ads ROI Optimization in 2025
Learn proven strategies to maximize your Google Ads return on investment with advanced bidding techniques, audience targ...

Google Ads Keyword Research: How to Find Profitable Keywords That Convert in 2025
Master Google Ads keyword research with advanced techniques to discover high-converting, low-conversion keywords that dr...

Google Ads Remarketing Lists for Search Ads (RLSA): Advanced Targeting for 280% Higher Conversions
Master Google Ads RLSA targeting to increase conversions by 280% and reduce costs by 45%. Learn advanced remarketing str...
